Global Intravenous Infusion Pumps Outlook 2025, Forecast To 2034
24 Mar, 2025
What Has Been The Evolution of the Intravenous Infusion Pumps Market in Recent Years?
The intravenous infusion pumps market has seen considerable growth due to a variety of factors.
• The market size for intravenous infusion pumps has seen a robust expansion in the last few years. There would be an increase from $5.99 billion in 2024 to $6.42 billion in 2025 with a 7.1% compound annual growth rate (CAGR). The significant growth during the historic period was driven by factors such as the rise in neurological disorders, the aging demographic, increasing awareness and diagnosis of strokes, and a multidisciplinary approach.
What Are the Future Growth Projections for the Intravenous Infusion Pumps Market?
The intravenous infusion pumps market is expected to maintain its strong growth trajectory in upcoming years.
• Strong expansion is anticipated in the market size of intravenous infusion pumps over the next few years. The market is predicted to escalate to $9.27 billion in 2029 with a compound annual growth rate (CAGR) of 9.6%.
The projected growth during this period can be credited to factors such as the popularity of minimally invasive procedures, growth in emerging markets, regulatory backing and reimbursement, alongside telehealth and remote consultations. Key trends expected to emerge during the forecast period are artificial intelligence (AI) and image analysis, robotics and navigation, patient-specific devices, and hybrid operating rooms.
What Are The Core Factors Supporting Growth In The Intravenous Infusion Pumps Market?
Expectations for the intravenous infusion pumps market's growth are being fueled by the increasing prevalence of chronic diseases. These infusion pumps, which administer pharmaceutical drugs, play a crucial role in treating these diseases. The aging population and shifts in societal behavior are contributing to a worldwide increase in chronic ailments, which are widespread, costly, and require long-term medical care. Infusion pumps, which deliver precise doses of nutrients or drugs such as chemotherapy medicines, painkillers, antibiotics, insulin, or other hormones to a patient's body, are vital tools in the treatment plan. For instance, as reported by the Australian Bureau of Statistics in March 2022, over forty-five percent (46.6%, or about 11.6 million) of the Australian population suffered from at least one chronic disease. Hence, the escalating prevalence of chronic diseases will undoubtedly stimulate growth in the intravenous infusion pumps market.
What Are The Major Segments Within The Global Intravenous Infusion Pumps Market?
The intravenous infusion pumps market covered in this report is segmented –
1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products
2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users
Subsegments:
1) By Volumetric: Large-volume Pumps, Small-volume Pumps
2) By Syringe: Micro Syringe Pumps, Macro Syringe Pumps
3) By Enteral: Portable Enteral Pumps, Stationary Enteral Pumps
4) By Ambulatory: Patient-controlled Analgesia (PCA) Pumps, Insulin Pumps, Disposable Pumps
5) By IV Disposables: IV Tubing Sets, IV Catheters, IV Cannulas, IV Solutions
6) By Other Products: Implantable Pumps, Smart Pumps, Elastomeric Pumps
What Trends Are Shaping The Intravenous Infusion Pumps Market?
The surge in technological advancements is an expanding trend seen in the intravenous infusion pumps market. Thanks to these developments, there's been a shift in how medical care is administered, with an increase in the use of smart intravenous infusion pumps. These allow for self-administration of fluids outside of the hospital environment, enabling patients to continue their daily routines. This not only reduces potential medication errors, but also minimizes harm to the patient. Major players investing in this smart pump technology include Fresenius Kabi, Q-Core Medical, Becton Dickinson, Micrel Medical Devices, and Baxter International. There have been specific product launches too, such as the next generation of Syringe Infusion Pumps by Chennai-based firm vTitan, which are specially designed for use in critical care scenarios in both hospitals and homes, ensuring safe and reliable delivery of medication.
Who Are the Key Players In The Intravenous Infusion Pumps Market?
Major companies operating in the intravenous infusion pumps market include:
• B. Braun Melsungen AG
• Baxter International Inc.
• Medtronic plc
• Fresenius Kabi AG
• Smiths Medical Inc.
• Becton Dickinson and Company (BD)
• Terumo Corporation
• F. Hoffmann-La Roche Ltd.
• ICU Medical Inc.
• IRadimed Corporation
• Mindray Medical International Limited
• Zyno Medical LLC
• Tandem Diabetes Care Inc.
• Johnson & Johnson
• Micrel Medical Devices SA
• Boston Scientific Corporation
• Pfizer Inc.
• Q-Core Medical Ltd.
• Moog Inc.
• Roche Diagnostics International AG
• Nipro Corporation
• Animas Corporation
• Ypsomed Holding AG
• Valeritas Inc.
• ZOLL Medical Corporation
• Codan Medical A/S
• Halyard Health Inc.
• InfuSystem Holdings Inc.
• Hospira Infusion Systems
• CareFusion Corporation
What Is The Most Dominant Region In The Intravenous Infusion Pumps Market?
North America was the largest region in the intravenous infusion pumps market in 2023. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa